1. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Issue 10 (13th March 2020) Authors: Puduvalli, Vinay K; Wu, Jing; Yuan, Ying; Armstrong, Terri S; Vera, Elizabeth; Wu, Jimin; Xu, Jihong; Giglio, Pierre; Colman, Howard; Walbert, Tobias; Raizer, Jeffrey; Groves, Morris D; Tran, David; Iwamoto, Fabio; Avgeropoulos, Nicholas; Paleologos, Nina; Fink, Karen; Peereboom, David; Chamberla... Journal: Neuro-oncology Issue: Volume 22:Issue 10(2020) Page Start: 1505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS. (5th November 2018) Authors: Puduvalli, Vinay; Wu, Jing; Yuan, Ying; Armstrong, Terri; Wu, Jimin; Giglio, Pierre; Xu, Jihong; Colman, Howard; Walbert, Tobias; Raizer, Jeffrey; Groves, Morris; Iwamoto, Fabio; Tran, David; Avgeropoulos, Nicholas; Paleologos, Nina; Fink, Karen; Peereboom, David; Chamberlain, Marc; Merrell, Ryan... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402. (11th November 2019) Authors: Lassman, Andrew; Won, Minhee; Gregory Cairncross, J; Shaw, Edward; Ashby, Lynn; Souhami, Luis; Laack, Nadia; Fink, Karen; Macdonald, David; Bahary, Jean-Paul; Hartford, Alan; Whitton, Anthony; Werner-Wasik, Maria; Laperriere, Normand; Suh, John; Robinson, Clifford; Mehta, Minesh Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-19. A MULTICENTER PILOT PHASE II STUDY OF CONTINUING TMZ WITH THE ADDITION OF DISULFIRAM AND COPPER FOR REFRACTORY GLIOBLASTOMA. (5th November 2018) Authors: Huang, Jiayi; Chaudhary, Rehka; Cohen, Adam; Fink, Karen; Godlust, Samuel; Boockvar, John; Chinnaiyan, Prakash; Marcus, Stephen; Campian, Jian Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BIOM-24. IDENTIFYING VULNERABILITY SIGNATURES THROUGH MACHINE LEARNING IN AN UMBRELLA TRIAL FOR GLIOBLASTOMA. (9th November 2020) Authors: Lee, Matthew; Tang, Nanyun; Ahluwalia, Manmeet; Fonkem, Ekokobe; Fink, Karen; Dhruv, Harshil; Berens, Michael; Peng, Sen Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CLRM-01. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST). (21st September 2021) Authors: Peng, Sen; Lee, Matthew; Tang, Nanyun; Ahluwalia, Manmeet; Fonkem, Ekokobe; Fink, Karen; Raizer, Jeffrey; Walker, Christopher; Dhruv, Harshil; Berens, Michael Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTIM-11. PHASE 2 STUDY OF SL-701, A NOVEL IMMUNOTHERAPY, IN ADULTS WITH RECURRENT GBM: A HIGH PARAMETER FLOW CYTOMETRY ANALYSIS OF CD8+ T CELLS AND POTENTIAL IMPLICATIONS FOR PATIENT ENRICHMENT STRATEGIES. (12th November 2021) Authors: Peereboom, David; Lindsay, Ross; Badruddoja, Michael; Nabors, L Burt; Kumthekar, Priya; Lieberman, Frank; Tran, David; Phuphanich, Surasak; Schiff, David; Sherman, Jonathan; Butowski, Nicholas; Dunbar, Erin; Fink, Karen; Iwamoto, Fabio; Moertel, Christopher; Schulder, Michael; Walbert, Tobias; Ha... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTIM-27. AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IMPROVES SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: SURVIVAL RESULTS FROM A PHASE 3 TRIAL. (14th November 2022) Authors: Liau, Linda M; Ashkan, Keyoumars; Brem, Steven; Campian, Jian; Trusheim, John; Iwamoto, Fabio; Tran, David; Anstass, George; Cobbs, Charles; Heth, Jason; Salacz, Michael; D'Andre, Stacy; Aiken, Robert; Moshel, Yaron; Nam, JooYeon; Pillainayagam, Clement; Wagner, Stephanie; Walter, Kevin; Chaudary... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GBM: IDENTIFICATION OF TREATMENT-INDUCED CD8+CD107A+ CD57+ PD-1- MEMORY T-CELLS THAT ARE ASSOCIATED WITH INCREASED SURVIVAL. (14th November 2022) Authors: Peereboom, David; Lindsay, Ross; Badruddoja, Michael; Nabors, L Burt; Kumthekar, Priya; Lieberman, Frank; Tran, David; Phuphanich, Surasak; Schiff, David; Sherman, Jonathan; Butowski, Nicholas; Dunbar, Erin; Fink, Karen; Iwamoto, Fabio; Moertel, Christopher; Schulder, Michael; Walbert, Tobias; Ha... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTNI-08. DB102-01 ENGAGE STUDY: A BIOMARKER-GUIDED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER PHASE 3 CLINICAL TRIAL OF DB102 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). (12th November 2021) Authors: Bota, Daniela; Butowski, Nicholas; Piccioni, David; De la Fuente, Macarena; Mao, Ying; Li, Wen-Bin; Trusheim, John; Fink, Karen; Campian, Jian; Lobbous, Mina; Portnow, Jana; Zhu, Jay-Jiguang; Pearlman, Michael; Rudnick, Jeremy; Lesser, Glen; Drappatz, Jan; Vaillant, Brian; Sun, Show-Li; Luo, Wen Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗